Invention Grant
- Patent Title: Bicyclic-fused heteroaryl or aryl compounds
-
Application No.: US16996117Application Date: 2020-08-18
-
Publication No.: US11702424B2Publication Date: 2023-07-18
- Inventor: John David Trzupek , Katherine Lin Lee , Mark Edward Bunnage , Seungil Han , David Hepworth , Frank Eldridge Lovering , John Paul Mathias , Nikolaos Papaioannou , Betsy Susan Pierce , Joseph Walter Strohbach , Stephen Wayne Wright , Christoph Wolfgang Zapf , Lori Krim Gavrin , Arthur Lee , David Randolph Anderson , Kevin Joseph Curran , Christoph Martin Dehnhardt , Eddine Saiah , Joel Adam Goldberg , Xiaolun Wang , Horng-Chih Huang , Richard Vargas , Michael Dennis Lowe , Akshay Patny
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Main IPC: C07D491/056
- IPC: C07D491/056 ; C07F7/18 ; C07D401/14 ; C07D405/14 ; C07D217/02 ; C07D217/22 ; C07D217/24 ; C07D239/86 ; C07D239/88 ; C07D263/24 ; C07D207/273 ; C07D498/04 ; C07D209/52 ; A61K31/4015 ; A61K31/47 ; A61K31/4709 ; A61K31/4725 ; A61K31/517 ; A61K31/5377 ; C07C69/94 ; A61K31/541 ; A61K45/06 ; C07D207/26 ; C07D215/48 ; C07D401/12 ; C07D403/12 ; C07D405/12 ; C07D407/14 ; C07D413/12 ; C07D417/12 ; C07D487/04 ; A61K31/40 ; C07D207/08 ; C07D207/267
Abstract:
Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia,
as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Public/Granted literature
- US20200377511A1 Bicyclic-Fused Heteroaryl or Aryl Compounds Public/Granted day:2020-12-03
Information query
